Compounded tirzepatide

Alan Meds

Alan Meds advertises $325 a month for compounded tirzepatide. We have not been able to confirm what the card is actually charged.

Advertised monthly$325
EvidenceReported
Billing cyclenot confirmed
Price across dosesSame at every dose
Where it ships46 states
FDA warning letterOne on filestill listed here

Visit Alan Meds →

The provider price index shows published quotes separately when the charge or billing interval is missing. Ask Alan Meds for both before using the quote to budget for a month. Among the sellers we work with, the Belle Health review and the YourEra review cover the sellers nearest in recorded price; we may earn a commission from those sellers.

What it bills, and what that is per month

The $325 above is the seller's own monthly figure. It does not say how often the card is actually charged, so we cannot restate it over a calendar month or check it against a checkout.

Where it says it operates

Listed in 46 states, all but 5 of the 51 we track.

What else this seller sells

The same seller appears in our data for one other medication.

Advertised figures have not been converted to a calendar month. These medications are priced separately from compounded tirzepatide. How the two molecules compare at every seller that sells both: compounded tirzepatide vs compounded semaglutide.

FDA has written to this seller

In , FDA sent warning letter 721814 to Alan Health Technologies Inc. dba Alan. The letter’s subject:

False & Misleading Claims/Misbranded (Telehealth)

Read the letter on fda.gov · The letter names alanmeds.com — the same site this page links to.

This seller stays in the index, at its real price. A warning letter is something you should see and weigh for yourself — an index that quietly dropped the worst records would be least useful exactly when it matters most. How we screen for these →